◀ Back to MAPK9

MAPK9 — SMAD7

Text-mined interactions from Literome

Wrana et al., Science's STKE : signal transduction knowledge environment 2000 : In the cytosol, Smad translocation might be inhibited by mitogen activated protein kinase dependent phosphorylation, whereas in the nucleus Smads interact with a number of transcription factors that themselves are primary targets of other signaling pathways
Akel et al., Platelets 2007 (Leukemia, Erythroblastic, Acute...) : Stable over-expression of Smad7 in K562 cells ( K562/7 ) prevented activation of Smad2/3 and MAPK ( ERK1/2, p38 and JNK1/2 ) proteins by activin-A/TGF-beta1 and subsequent induction of erythroid differentiation
Zhao et al., Mol Cell Biochem 2008 (Fibrosis...) : Additionally, the inhibition of MAPK signaling had no effect on Smad activation elicited by chymase
Shukla et al., Am J Respir Cell Mol Biol 2009 (MAP Kinase Signaling System...) : HGF induced expression of Smad7 , an inhibitor of TGF-beta signaling, in a mitogen activated protein kinase dependent manner
Zhu et al., Prostate 2010 (MAP Kinase Signaling System) : These findings suggest a dual role for PHB as a downstream determinant of the cellular response to TGF-beta via Smad dependent pathway ( apoptosis ) and MAPK intracellular signaling ( survival )
Rodrigues Díez et al., PloS one 2010 (Fibrosis) : In cultured rat VSMCs, direct AngII/Smad pathway activation was mediated by p38 MAPK and ROCK activation
Ungefroren et al., Int J Oncol 2011 (Carcinoma, Pancreatic Ductal...) : Biochemically, dnSrc inhibition failed to block TGF-ß1/ALK5 induced activation of Smad2 and Smad3, but partially inhibited transcriptional activation of TGF-ß/Smad-responsive reporter genes, and effectively blocked basal and TGF-ß1 induced activation of p38 MAPK